6:00 PM - 6:25 PM
○Hiroko Shibata, Masato Kiyoshi, Akira Harazono, Akiko Ishii (DBCB, NIHS)
Workshop
Thu. Jun 17, 2021 6:00 PM - 8:30 PM Channel 3
Organizers: Susumu Uchiyama (Osaka Univ.), Akiko Ishii (National Institute of Health Sciences)
Many biopharmaceutical products, mainly antibody drugs, have been put into practical use. In recent years, different modalities utilizing protein engineering technologies such as bispecific antibodies have been developed, and it has become necessary to solve unique problems in quality control and regulation. On the other hand, gene therapy products using recombinant viruses have also appeared, and more complicated analysis and quality control are required. In this workshop, in addition to biopharmaceuticals, gene therapy products will be discussed by researchers who are leading the field, explaining the background and current situation, and issues from the aspect of protein science.
6:00 PM - 6:25 PM
○Hiroko Shibata, Masato Kiyoshi, Akira Harazono, Akiko Ishii (DBCB, NIHS)
6:25 PM - 6:50 PM
○Satoshi Saitoh (Quality Development Dept., Chugai Pharm.)
6:50 PM - 7:10 PM
○Saki Yoneda1, Takahiro Maruno1, Asuka Mori1, Ayana Hioki1, Haruka Nishiumi1, Ayano Fukuhara2, Yosuke Harauchi3, Satoru Adachi3, Kumi Okuyama3, Taichi Sawaguchi3, Tetsuo Torisu1, Susumu Uchiyama1,4 (1.Dept. Biotech. Grad. Sch. Eng. Osaka. Univ., 2.U-Medico Inc., 3.ZEON Corp., 4.ExCELLS)
7:10 PM - 7:40 PM
○Takashi Okada (Div. of Mol. Med. Gen., Univ. of Tokyo)
7:40 PM - 8:05 PM
○Junichi Mineno (Takara Bio Inc.)
8:05 PM - 8:30 PM
○Susumu Uchiyama (Dept. Biotech., Grad Sch. Eng., Osaka Univ.)